Zacks Investment Research upgraded shares of Ceridian HCM (NYSE:CDAY – Get Rating) from a hold rating to a buy rating in a research note issued to investors on Wednesday morning, Zacks.com reports. Zacks Investment Research currently has $59.00 target price on the stock. According to Zacks, “Ceridian HCM Holding Inc. provides human capital management software […]